Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective

This publication has 72 references indexed in Scilit:

• Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
  European Journal of Cancer, 2023
• Integrated longitudinal circulating tumor DNA profiling predicts immunotherapy response of metastatic urothelial carcinoma in the POLARIS‐03 trial
  The Journal of Pathology, 2023
• Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer
  Molecular Oncology, 2022
• Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results
  Cancer, 2020
• Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
  EBioMedicine, 2019
• Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?
  European Journal of Cancer, 2018
• The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder
  World Journal of Urology, 2018
• Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
  Cancer, 2018
• The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour
  The Journal of Pathology, 2008
• The role of urinary cytology for detection of bladder cancer
  European Journal of Surgical Oncology, 2005